Solu-cortef and Cytosar-u drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Solu-cortef (hydrocortisone sodium succinate) and Cytosar-u (cytarabine). Common drug interactions include ataxia among females and convulsions among males.

The phase IV clinical study analyzes what interactions people have when they take Solu-cortef and Cytosar-u. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Solu-cortef?

Solu-cortef has active ingredients of hydrocortisone sodium succinate. eHealthMe is studying from 7,983 Solu-cortef users. Check the latest studies of Solu-cortef.

What is Cytosar-u?

Cytosar-u has active ingredients of cytarabine. eHealthMe is studying from 586 Cytosar-u users. Check the latest studies of Cytosar-u.



On Jul, 28, 2026

16 people who take Solu-cortef and Cytosar-u together, and have interactions are studied.

Solu-cortef and Cytosar-u drug interactions.

What are the common drug interactions of Solu-Cortef and Cytosar-U, by gender? *:

female:

  1. Ataxia (loss of full control of bodily movements)
  2. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Streptococcal sepsis (whole body inflammation by streptococcal)
  5. Coma (state of unconsciousness lasting more than six hours)
  6. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  7. Encephalopathy (functioning of the brain is affected by some agent or condition)
  8. Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
  9. Mucosal inflammation (infection of mucous membrane)
  10. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)

male:

  1. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  2. Dementia (madness)
  3. Partial seizures (seizures which affect only a part of the brain at onset)
  4. Thyroiditis acute (rapid inflammation of thyroid gland)
  5. Thyrotoxicosis (a morbid condition due to over activity of the thyroid gland)
  6. Toxic encephalopathy (a degenerative neurologic disorder caused by exposure to toxic substances)
  7. Cellulitis (infection under the skin)
  8. Erythema (redness of the skin)
  9. Gingivitis (inflammation of gums)
  10. Leukaemia relapse (failing of blood cancer or bone marrow cancer)

What are the common drug interactions of Solu-Cortef and Cytosar-U, by age (0-1 to 60+)? *:

0-1:

  1. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)

2-9:

  1. Encephalopathy (functioning of the brain is affected by some agent or condition)
  2. Paralysis flaccid (abnormal condition characterized by the weakening or the loss of muscle tone)
  3. Partial seizures (seizures which affect only a part of the brain at onset)
  4. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  5. Ataxia (loss of full control of bodily movements)
  6. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  7. Streptococcal sepsis (whole body inflammation by streptococcal)
  8. Coma (state of unconsciousness lasting more than six hours)

10-19:

  1. Cellulitis (infection under the skin)
  2. Erythema (redness of the skin)
  3. Gingivitis (inflammation of gums)
  4. Leukaemia relapse (failing of blood cancer or bone marrow cancer)
  5. Neck swelling
  6. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
  7. Neutropenia (an abnormally low number of neutrophils)
  8. Paralysis flaccid (abnormal condition characterized by the weakening or the loss of muscle tone)
  9. Partial seizures (seizures which affect only a part of the brain at onset)
  10. Thyroiditis acute (rapid inflammation of thyroid gland)

20-29:

n/a

30-39:

  1. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  2. Mental impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition)
  3. Mucosal inflammation (infection of mucous membrane)

40-49:

n/a

50-59:

n/a

60+:

  1. Dementia (madness)
  2. Toxic encephalopathy (a degenerative neurologic disorder caused by exposure to toxic substances)

What are the existing conditions these people have? *

  1. Burkitt's Lymphoma (cancer of the lymphatic system): 2 people, 12.50%
  2. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Solu-cortef and Cytosar-u?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Solu-cortef and Cytosar-u:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Solu-cortef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cytosar-u:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Solu-cortef and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cytosar-u and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydrocortisone sodium succinate and cytarabine (the active ingredients of Solu-cortef and Cytosar-u, respectively), and Solu-cortef and Cytosar-u (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: